Detalles de la búsqueda
1.
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Ann Oncol
; 26(9): 1923-1929, 2015 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26091808
2.
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Ann Oncol
; 27(6): 1180, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26945010
3.
A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer.
Ann Oncol
; 26(12): 2505, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26489442
Resultados
1 -
3
de 3
1
Próxima >
>>